Ampio Pharmaceuticals Company Description

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States.

The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.

Ampio Pharmaceuticals, Inc.

Country	United States
Industry	Biotechnology
Sector	Healthcare
Employees	6
CEO	Michael Martino

Contact Details

Address: 9800 Mount Pyramid Court Englewood, Delaware 80112 United States
Phone	720 437 6500
Website	ampiopharma.com

Stock Details

Ticker Symbol	AMPE
Exchange	OTCMKTS
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US03209T3077
SIC Code	2834

Key Executives

Name	Position
Michael A. Martino	Chief Executive Officer, Chief Financial Officer, General Secretary and Director
Dr. David Bar-Or M.D.	Founder and Chairman of Scientific Advisory Board
April Ramirez	Clinical Trial Manager